Cardiac Triple
- UID
- IMP/IVD/2020/000059_e75de94916bc5c20c62ef7bbf514d695_2b03b466d66525cd5ea5a2ad5f0d1784
- Device class
- Class B
- Brand name
- ichroma™ ST2
- License holder
- Kin Diagnostics
- Approving authority
- CDSCO
- Product information
- ichroma™ Cardiac Triple is a Fluorescence Immunoassay (ichroma™ ST2) for the quantitative determination of cardiac troponin‐I (ichroma™ ST2), Creatine kinase (ichroma™ ST2) and Myoglobin in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of acute myocardial infarction (ichroma™ ST2) and acute coronary syndrome (ichroma™ ST2). For in vitro diagnostic use only
Cardiac Triple is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000059_e75de94916bc5c20c62ef7bbf514d695_2b03b466d66525cd5ea5a2ad5f0d1784. This device is marketed under the brand name ichroma™ ST2. The license holder is Kin Diagnostics, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.